date:May 07, 2013
he Journal of the American Medical Association.
A subgroup analysis in 1,055 eyes indicates that subjects with the lowest quintile of dietary intake of lutein and zeaxanthin (median 0.7 mg per day) but supplemented with 10 mg FloraGLO Lutein and 2 mg of OPTISHARP Zeaxanthin had a significant risk reduction of 26% for progression to advanced AMD. These findings, said DSM, affirm the role of lutein and zeaxanthin as important contributors to risk reduction of AMD progression and the authors ackno